Neri B, Cini-Neri G, D'Alterio M
Biochem Biophys Res Commun. 1984 Dec 28;125(3):954-60. doi: 10.1016/0006-291x(84)91376-7.
The clinical use of anthracycline antibiotics is severely limited by dose-dependent cardiotoxicity. This accounts for our interest in differences on respiratory control of cardiac cells induced by two new anticancer agents epirubicin and mitoxantrone. Cellular oxygen uptake was measured for increasing drugs concentrations with a Warburg manometric apparatus and intracellular ATP by high-pressure liquid chromatography in rat heart slices incubated for 60' with anthracyclines or mitoxantrone. Epirubicin inhibits endogenous respiration by 18% versus control while doxorubicin and mitoxantrone reduce oxygen uptake by 34 and 46%, respectively. ATP intracellular concentration was significantly reduced by all anti-cancer agents but particularly by mitoxantrone 86%. These results may be related to the biochemical side effects produced by these drugs on bioenergetics and cellular respiratory control.
蒽环类抗生素的临床应用因剂量依赖性心脏毒性而受到严重限制。这引发了我们对两种新型抗癌药物表柔比星和米托蒽醌诱导的心脏细胞呼吸控制差异的兴趣。使用瓦氏测压仪测定随着药物浓度增加时细胞对氧气的摄取,并通过高压液相色谱法测定在与蒽环类药物或米托蒽醌孵育60分钟的大鼠心脏切片中的细胞内ATP含量。与对照组相比,表柔比星抑制内源性呼吸达18%,而阿霉素和米托蒽醌分别使氧气摄取减少34%和46%。所有抗癌药物均使细胞内ATP浓度显著降低,尤其是米托蒽醌,降低了86%。这些结果可能与这些药物对生物能量学和细胞呼吸控制产生的生化副作用有关。